Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
This clinical trial update describes the use of the PET imaging agent 18F-fluorothymidine (18F-FLT) in cancer patients to assess tumor proli…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Pilot Study of an NTproBNP Guided Strategy of Cardioprotection [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating an NTproBNP-guided cardioprotection strategy to reduce chemotherapy-related cardiotoxicity in cancer …
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers [Phase 1]
Phase 1 study results for TTX-030 as a single agent and in combination with immunotherapy or chemotherapy in patients with advanced solid tu…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: CD30 CAR-T in the Treatment of CD30 Positive Lymphoma [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating a CD30-targeted CAR-T therapy for CD30-positive lymphomas is listed as not yet recruiting, sponso…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer
Completed clinical trial from Institut Bergonié evaluating elderly patients' expectations and priorities for a first-line cancer treatment a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer [Phase 1]
A Phase I safety and pharmacokinetic study of intravenously administered Gamitrinib in patients with advanced cancer is ongoing, including l…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas [Phase 1]
Phase 1 trial assessing safety and pharmacokinetics of HMPL-689 in patients with lymphoma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (In Vivo Phase) [NA]
Sponsored by the University of Exeter, the DOLPHIN-VIVO trial (NCT05010369) investigates in vivo diagnosis of lymphoma. The study has been t…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Registry of Older Patients With Cancer
This clinical trial registry entry from UNC Lineberger indicates an ongoing recruitment for a registry of older patients with cancer, includ…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies [NA]
A clinical trial is recruiting to evaluate an investigational CAR-T cell therapy for hematologic malignancies, including acute lymphoblastic…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
Samsung Medical Center is conducting a prospective cohort study of lymphoma and is currently recruiting participants.
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Virus-associated Tumour Microenvironment: Characterisation and Immunological Mechanisms of Resistance to Anti-tumour Treatments
This clinical trial aims to characterize the virus-associated tumour microenvironment and immunological resistance mechanisms to anti-tumour…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
An ongoing clinical trial update describes using phased variant analysis with next-generation sequencing to enable early assessment of lymph…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas [Phase 1, Phase 2]
The PROCLAIM-CX-072 Phase 1/2 trial evaluating CX-072 for solid tumors and lymphomas has been terminated with results posted.
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma [Phase 1]
Phase 1 clinical trial of CD22-CAR T cell immunotherapy for CD22-positive leukemia and lymphoma.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia
Clinical trial update from the Montreal Heart Institute describing efforts to identify and evaluate patients at risk of developing chemother…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies [Phase 1, Phase 2]
This clinical trial update describes the PACMAN-Hu19 trial evaluating the safety and feasibility of locally produced, CD19-targeted CAR T-ce…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease [NA]
A clinical trial is evaluating the Go Wish Game to promote advance care planning in patients with leukemia, multiple myeloma, and other onco…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy
Clinical trial comparing ATLG versus ATG for immune reconstitution after allogeneic hematopoietic stem cell transplantation in hematologic m…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies [Phase 1]
Phase 1 trial update describing the use of allogeneic Epstein-Barr virus-specific cytotoxic T-lymphocytes targeted to CD19 for B-cell malign…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study
A prospective, multicenter clinical study evaluating the value of monitoring circulating cell DNA (ctDNA) in pediatric lymphoma patients.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer [NA]
This clinical trial update describes a study on integrative neuromuscular training for children and adolescents treated for cancer, sponsore…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis [Phase 2]
A Phase 2 trial (ABBA CORD) evaluating donor-derived cord blood T cells with abatacept for prophylaxis of acute graft-versus-host disease in…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer's rituximab biosimilar intravenous infusion (100 mg and 500 mg) was investigated in a post-marketing database study for lymphoma, and…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
An ongoing clinical trial is evaluating whether dexrazoxane hydrochloride affects biomarkers linked to cardiomyopathy and heart failure afte…